found that the lncRNA SBF2-AS1 enhances temozolomide resistance in GBM (19), and HAS2-AS1, which is located at the 8q24.13 locus, was reported to be an oncogene in oral squamous cell carcinoma (20). Here, HAS2 is linked to glioblastoma.